Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)
Code:
NCT06732414
Conditions
Allergy, Sinus Disorders, Atopic Diseases, Asthma, Allergic Rhinitis, Atopic Dermatitis, EoE, Drug a
Eligibility Criteria
Sex: All
Age: 3 - 70+
Healthy Volunteers: Not accepted
Brief summary:
Conditions
Allergy, Sinus Disorders, Atopic Diseases, Asthma, Allergic Rhinitis, Atopic Dermatitis, EoE, Drug a
Study ID
NCT06732414
Start date
Jan 28, 2025
Status verified date
Jul 15, 2026
Completion date
Nov 1, 2045
Anticipated
Primary completion date
Nov 1, 2044
Anticipated
Eligibility Criteria
Sex: All
Age: 3 - 70+
Healthy Volunteers: Not accepted
Enrollment
10000 participants
Anticipated
Arms
Conditions that may be initially evaluated or managed by A&I but not categorized in 1 or 2 above
Individuals with a suspected allergic or atopic disease
Individuals with an allergic, atopic, or sinus disease
Primary outcome measure
Central contacts
Locations
National Institutes of Health Clinical Center
Recruiting
Bethesda, Maryland, United States, 20892
Contacts
Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Last update posted
Jul 17, 2026
Last verified
Jul 15, 2026
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by National Institute of Allergy and Infectious Diseases (NIAID) on 2026-07-17.